BSE Live
Mar 02, 16:01Prev. Close
4.43
Open Price
4.43
Bid Price (Qty.)
4.43 (83500)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Cresanto Global (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | -0.04 | -0.12 | -0.15 | -0.15 | 0.03 | |
| Diluted EPS (Rs.) | -0.04 | -0.12 | -0.15 | -0.15 | 0.03 | |
| Cash EPS (Rs.) | -0.04 | -0.11 | -0.12 | -0.12 | 0.07 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | -4.05 | -4.01 | -3.89 | -3.74 | -3.62 | |
| Book Value [InclRevalReserve]/Share (Rs.) | -4.05 | -4.01 | -3.89 | -3.74 | -3.62 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 0.00 | 0.00 | 0.00 | 0.44 | 0.45 | |
| PBDIT/Share (Rs.) | -0.04 | -0.03 | -0.07 | 0.00 | 0.10 | |
| PBIT/Share (Rs.) | -0.04 | -0.03 | -0.10 | -0.04 | 0.06 | |
| PBT/Share (Rs.) | -0.04 | -0.12 | -0.15 | -0.15 | 0.03 | |
| Net Profit/Share (Rs.) | -0.04 | -0.12 | -0.15 | -0.15 | 0.03 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 0.00 | 0.00 | 0.00 | -0.83 | 21.19 | |
| PBIT Margin (%) | 0.00 | 0.00 | 0.00 | -8.82 | 12.64 | |
| PBT Margin (%) | 0.00 | 0.00 | 0.00 | -35.13 | 7.24 | |
| Net Profit Margin (%) | 0.00 | 0.00 | 0.00 | -35.13 | 7.24 | |
| Return on Networth / Equity (%) | 0.00 | 0.00 | 0.00 | 0.00 | -0.90 | |
| Return on Capital Employed (%) | 1.05 | 0.74 | 2.66 | 1.03 | -0.90 | |
| Return on Assets (%) | -6.03 | -16.48 | -12.62 | -10.54 | 1.81 | |
| Total Debt/Equity (X) | -1.15 | -1.15 | -1.29 | -1.34 | -1.44 | |
| Asset Turnover Ratio (%) | 0.00 | 0.00 | 0.00 | 30.00 | 24.99 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 0.05 | 0.05 | 0.13 | 0.17 | 0.22 | |
| Quick Ratio (X) | 0.05 | 0.05 | 0.13 | 0.17 | 0.17 | |
| Inventory Turnover Ratio (X) | 0.00 | 0.00 | 0.00 | 128.56 | 1.66 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 100.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 100.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 3.74 | 6.22 | 5.72 | 15.01 | 6.02 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 80.18 | 31.10 | |
| EV/EBITDA (X) | -204.75 | -579.39 | -186.66 | -9,553.65 | 146.75 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 69.17 | 19.81 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 100.00 | |
| Price/BV (X) | -1.01 | -2.49 | -2.17 | -8.11 | -2.49 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 69.18 | 19.82 | |
| Earnings Yield | -0.01 | -0.01 | -0.02 | -0.01 | 0.00 |
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth